Abstract CT176: OBX-115 Engineered Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy Induced Deepening and Durable Responses Without Interleukin 2 (IL2) in Patients (pts) with Immune Checkpoint Inhibitor (Ici)-Resistant Unresectable or Metastatic Melanoma
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined